Switchable Pamam Megamers for Deep Tumor Penetration and Enhanced Cell Uptake Publisher Pubmed

Summary: Smarter cancer drug delivery? Study’s SChPMs shrink to 15nm at tumor pH, boost DOX uptake—cuts resistance. #CancerTherapy #Nanomedicine

Nekoueifard E^{1, 2, 3} ; Radmanesh F^{2, 7} ; Zarkesh I² ; Ebrahimi M⁵ ; Raoufi M³ ; Abandansari HS^{2, 4} ; Baharvand H^{5, 6} ; Dinarvand R^{1, 3, 8}
Source: Journal of Controlled Release Published:2024

Abstract

Nanoparticles fabricated to deliver anticancer drugs are usually designed to present optimized tumor penetration and cell internalization. However, there are some barriers and difficulties with most current technologies. Herein, size and charge switchable polyamidoamine (PAMAM) megamers (SChPMs) were prepared for the delivery of doxorubicin (DOX). SChPMs were fabricated by connecting PAMAM dendrimers with pH-sensitive bonds and surface PEGylation. At pH 7.4, the size and surface charge of these nanocarriers were approximately 100 nm and + 0.75 mV, but at the acidic extracellular pH of tumor cells (pH 6.5), their size were reduced dramatically (15 nm) and their surface charge increased to +6.7 mV. Cell studies confirmed that alteration of the size and surface charge enhanced their penetration into multicellular spheroids and cell internalization. These megamers, in addition to delivering the drug to the deeper areas of the tumor, could powerfully overcome physiological resistance to anthracycline-based drugs. The nanocarrier revealed enhanced antitumoral activity in animal studies. Toxicology studies and histopathological assessments of vital tissues of 4 T1 tumor bearing mice indicated minimal tissue damage when DOX-loaded SChPMs (DSChPMs) were used. It can be concluded that the versatile and agile nanocarriers developed in this study could be considered for further investigations into their clinical application. © 2024 Elsevier B.V.